Loading...

PR Information Data

130 개 3 페이지
번호 컨텐츠
100 AdipoLABs CEO Han Sung-ho was appointed as an advisory member of the Future Strategy Special Committee of the Constitutional Council. 2024-03-14   45 (주)아디포랩스
99 AdipoLABs and Cyberjaya University sign MOU for cancer treatment... “A great force in medical advancement” 2024-03-28   45 (주)아디포랩스
98 2022 IVRA International Medical Conference held successfully 2024-03-14   46 (주)아디포랩스
97 Willing to do his best until the day humanity is free from disease 2024-03-14   46 (주)아디포랩스
96 ‘K-Medical Device’ winning 1st place in Malaysian Oncology Society paper 2024-03-29   49 (주)아디포랩스
95 Presentation of REMISSION 1℃ hyperthermia cancer treatment case is expected to open up a new horizon in cancer treatment 2024-03-28   50 (주)아디포랩스
94 Korea's largest '2022 IVRA International Medical Conference' to be held 2024-03-14   52 (주)아디포랩스
93 Hyperthermia therapy, new cancer treatment method ‘established’ 2024-03-29   54 (주)아디포랩스
92 Attention is paid to “REMISSION 1℃” a medical high-frequency heater which is known as a cutting-edge medical device to overcome COVID-19 2024-03-12   56 (주)아디포랩스
91 Adipo LABs’ practice of ‘humanity’ that transcends borders 2024-03-12   58 (주)아디포랩스
90 ‘IVRA International Medical Conference’ held to share the latest knowledge on ‘cancer treatment-pain management’ 2024-03-14   59 (주)아디포랩스
89 Presenting a new direction for COVID-19/cancer treatment 2024-03-14   62 (주)아디포랩스
88 ‘IVRA’ opens new possibilities for overcoming COVID-19 and cancer 2024-03-14   66 (주)아디포랩스
87 ’'High-frequency heat treatment' that burns away cancer and even 'amplifies' immunity" 2024-02-16   70 (주)아디포랩스
86 High-frequency hyperthermia device REMISSION 1℃ receives European CE certification, attracting attention from Malaysian medical community 2024-02-15   72 (주)아디포랩스